3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia
10
Breast Neoplasms
10
Prostatic Neoplasms
8
Lymphoma, Follicular
8
Lymphoma
8
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
6
Adenocarcinoma of Lung
5
Rectal Neoplasms
4
Multiple Myeloma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Kidney Neoplasms
4
Hodgkin Disease
4
Congenital Abnormalities
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Neoplasms, Plasma Cell
3
Myeloproliferative Disorders
3
Myelodysplastic Syndromes
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Extranodal NK-T-Cell
3
Leukemia, Myeloid, Acute
3
Burkitt Lymphoma
3
Adenocarcinoma, Bronchiolo-Alveolar
3
Interventions
Doxorubicin
11
Razoxane
5
Dexrazoxane
5
Electrocardiography
4
Echocardiography
4
Cyclophosphamide
4
Vincristine
3
Trastuzumab
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Exercise
3
Etoposide
3
Carvedilol
3
Radiotherapy
2
Prednisone
2
Methotrexate
2
Magnetic Resonance Spectroscopy
2
Bleomycin
2
salicylhydroxamic acid
1
oblimersen
1
hydrocortisone hemisuccinate
1
dapagliflozin
1
Vascular Stiffness
1
VAP-cyclo protocol
1
Tablets
1
Silymarin
1
Reverse Transcriptase Polymerase Chain Reaction
1
Resistance Training
1
Pulse Wave Analysis
1
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cardiotoxicity
×
Amplified Fragment Length Polymorphism Analysis
×
Clear all
NCT00875238
2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
133 enrolled